Posts Tagged ‘spinal cord injury’
Prof. Bloch and Prof. Courtine New Breakthrough for SCI Patients
In a rare double publication in Nature and Nature Medicine, landmark studies led by Professor Grégoire Courtine (EPFL), Professor Jocelyne Bloch (CHUV and University of Lausanne), and Dr. Aaron Phillips (University of Calgary) describe the development of a targeted therapy to stabilize blood pressure in SCI patients. Working with EPFL spin-off ONWARD Medical, the team…
Read MoreONWARD Medical Receives CE Mark for ARC-EX®
ONWARD Medical, a Vaud-Based neurotechnology company, has achieved a major milestone with the CE Mark certification of its ARC-EX® System. This approval allows the company to launch its breakthrough spinal cord stimulation therapy across Europe, both for clinical and home use. The first commercial sales are expected in Q4 2025, starting in Germany before expanding…
Read MoreONWARD Medical Secures FDA Approval for First Non-Invasive Spinal Cord Stimulation System
ONWARD Medical has reached a significant milestone in spinal cord injury (SCI) treatment, receiving FDA de novo classification and U.S. market authorization for its ARC-EX System. This innovative device is the first non-invasive technology approved to improve hand strength and sensation in individuals with chronic SCI, offering hope to a community often told recovery is…
Read MoreEUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)
The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList. The company also received the First Place Winner of the 2022 Brain-Computer Interface (BCI) Award. ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in…
Read MoreONWARD’s Neurostimulator Restores Mobility for Patients with Spinal Cord Injury
This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the spinal cord to restore movement and autonomic functions for people with spinal cord injury and other conditions that affect mobility. This first implant on a human patient is a major milestone in ONWARD’s successful…
Read More